Literature DB >> 9712725

Ligand binding to the (1 --> 3)-beta-D-glucan receptor stimulates NFkappaB activation, but not apoptosis in U937 cells.

J Battle1, T Ha, C Li, V Della Beffa, P Rice, J Kalbfleisch, W Browder, D Williams.   

Abstract

Recent data suggest that sepsis stimulates macrophage apoptosis (Ao) with subsequent induction of macrophage dysfunction. Nuclear factor-kappaB (NFkappaB) activation has been linked to Ao in either a pro- or antiapoptotic role. Glucans are biological response modifiers which exert antisepsis activity. This investigation examined the effect of (1-3)-beta-D-glucan receptor binding by a high affinity ligand on Ao and NFkappaB activation in U937 cells in the presence or absence of LPS. A high affinity glucan ligand (IC50 = 23 nM) activated NFkappaB, but did not induce Ao or significantly alter LPS induced U937 Ao. These data indicate that: i) modulation of the macrophage (1-3)-beta-D-glucan receptor stimulates NFkappaB; ii) does not induce Ao or significantly diminish LPS induced Ao and iii) activation of the U937 FAS receptor does not alter the relative Ao responses in glucan and LPS treated cells. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712725     DOI: 10.1006/bbrc.1998.9175

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Targeting human dendritic cell subsets for improved vaccines.

Authors:  Hideki Ueno; Eynav Klechevsky; Nathalie Schmitt; Ling Ni; Anne-Laure Flamar; Sandra Zurawski; Gerard Zurawski; Karolina Palucka; Jacques Banchereau; Sangkon Oh
Journal:  Semin Immunol       Date:  2011-01-28       Impact factor: 11.130

2.  Immunological properties of complex conjugates based on Vibrio cholerae O1 Ogawa lipopolysaccharide antigen.

Authors:  E Paulovicová; E Machová; A Hostacká; S Bystrický
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

3.  Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma.

Authors:  M T Fitch; C Doller; C K Combs; G E Landreth; J Silver
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

4.  Dectin1 activation of β-(1-3)/(1-6)-D-glucan produces an anti-mastitis effect in rats.

Authors:  Wei Zhu; Beibei Gu; Jinfeng Miao; Jingye Lu; Sixiang Zou
Journal:  Inflamm Res       Date:  2011-06-21       Impact factor: 4.575

5.  Normal human fibroblasts express pattern recognition receptors for fungal (1-->3)-beta-D-glucans.

Authors:  P Kougias; D Wei; P J Rice; H E Ensley; J Kalbfleisch; D L Williams; I W Browder
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

6.  Cellular and molecular mechanisms of fungal β-(1→6)-glucan in macrophages.

Authors:  Ilka Noss; Tammy R Ozment; Bridget M Graves; Michael D Kruppa; Peter J Rice; David L Williams
Journal:  Innate Immun       Date:  2015-07-23       Impact factor: 2.680

7.  Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists.

Authors:  Haibin Huang; Gary R Ostroff; Chrono K Lee; Jennifer P Wang; Charles A Specht; Stuart M Levitz
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

8.  Medicinal mushrooms: Towards a new horizon.

Authors:  A Ganeshpurkar; G Rai; A P Jain
Journal:  Pharmacogn Rev       Date:  2010-07

9.  Beta-(1-->3)-D-glucan modulates DNA binding of nuclear factors kappaB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1beta/IL-1 receptor antagonist ratio.

Authors:  Juergen Luhm; Ulrich Langenkamp; Jenny Hensel; Christoph Frohn; Joerg M Brand; Holger Hennig; Lothar Rink; Petra Koritke; Nadine Wittkopf; David L Williams; Antje Mueller
Journal:  BMC Immunol       Date:  2006-03-22       Impact factor: 3.615

10.  CAM and NK Cells.

Authors:  Kazuyoshi Takeda; Ko Okumura
Journal:  Evid Based Complement Alternat Med       Date:  2004-06-01       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.